#lykos-therapeutics

[ follow ]
#fda
www.nytimes.com
1 month ago
Medicine

Opinion | How Psychedelic Research Got High on Its Own Supply

Lykos Therapeutics faced a significant setback with the F.D.A.'s rejection of their MDMA PTSD treatment application, raising concerns about trial integrity. [ more ]
Business Insider
1 month ago
Medicine

The drugmaker that hopes to legalize MDMA is cutting 75% of its staff after the FDA rejected the drug

Lykos Therapeutics is reducing its staff by 75% after the FDA rejected its MDMA drug for mental health treatment. [ more ]
www.nytimes.com
1 month ago
Medicine

Three Studies of MDMA Treatment Retracted by Scientific Journal

Psychopharmacology retracted papers on MDMA-assisted therapy due to unethical conduct at a study site. [ more ]
www.npr.org
1 month ago
Medicine

FDA gives thumbs down to MDMA for now, demanding further research

The FDA has requested further study on MDMA-assisted therapy for PTSD, dealing a blow to Lykos Therapeutics and the broader psychedelics movement. [ more ]
www.nytimes.com
1 month ago
Medicine

Opinion | How Psychedelic Research Got High on Its Own Supply

Lykos Therapeutics faced a significant setback with the F.D.A.'s rejection of their MDMA PTSD treatment application, raising concerns about trial integrity. [ more ]
Business Insider
1 month ago
Medicine

The drugmaker that hopes to legalize MDMA is cutting 75% of its staff after the FDA rejected the drug

Lykos Therapeutics is reducing its staff by 75% after the FDA rejected its MDMA drug for mental health treatment. [ more ]
www.nytimes.com
1 month ago
Medicine

Three Studies of MDMA Treatment Retracted by Scientific Journal

Psychopharmacology retracted papers on MDMA-assisted therapy due to unethical conduct at a study site. [ more ]
www.npr.org
1 month ago
Medicine

FDA gives thumbs down to MDMA for now, demanding further research

The FDA has requested further study on MDMA-assisted therapy for PTSD, dealing a blow to Lykos Therapeutics and the broader psychedelics movement. [ more ]
morefda
Axios
4 months ago
Medicine

FDA panel votes against ecstasy for PTSD

The FDA usually follows advisory committees' advice, with a decision expected on Lykos Therapeutics' drug application by Aug. 11. [ more ]
[ Load more ]